Gene PointNet for Tumor Classification

Hao Lu,Mostafa Rezapour,Haseebullah Baha,Muhammad Khalid Khan Niazi,Aarthi Narayanan,Metin Gurcan
DOI: https://doi.org/10.1101/2024.06.02.597020
2024-06-03
Abstract:The rising incidence of cancer underscores the imperative for innovative diagnostic and prognostic methodologies. This study delves into the potential of RNA-Seq gene expression data to enhance cancer classification accuracy. Introducing a pioneering approach, we model gene expression data as point clouds, capitalizing on the data's intrinsic properties to bolster classification performance. Utilizing PointNet, a typical technique for processing point cloud data, as our framework's cornerstone, we incorporate inductive biases pertinent to gene expression and pathways. This integration markedly elevates model efficacy, culminating in developing an end-to-end deep learning classifier with an accuracy rate surpassing 99%. Our findings not only illuminate the capabilities of AI-driven models in the realm of oncology but also highlight the criticality of acknowledging biological dataset nuances in model design. This research provides insights into application of deep learning in medical science, setting the stage for further innovation in cancer classification through sophisticated biological data analysis. The source code for our study is accessible at: https://github.com/cialab/GPNet.
Bioinformatics
What problem does this paper attempt to address?
The paper attempts to address the issue of improving the accuracy of diagnosis and prognosis in cancer classification. Specifically, the research team developed a new method by modeling gene expression data as point cloud data structures and utilizing the PointNet framework to process these data, thereby enhancing the performance of cancer classification. This approach not only improves classification accuracy but also considers the intrinsic properties of gene expression data, making the model more consistent with biological characteristics. The specific problems the paper attempts to solve are as follows: 1. **Improve the accuracy of cancer classification**: By introducing a new deep learning model—GenePointNet (GPNet), the model achieves an accuracy of over 99% in cancer classification tasks. 2. **Incorporate biological knowledge**: This method integrates inductive biases related to gene expression and pathways, enabling the model to better understand the relationships between genes. 3. **Discover potential biomarkers**: By identifying the genes deemed most important by the model, researchers can explore the relationship between these genes and tumor processes, providing new avenues for the future discovery of effective cancer biomarkers. In summary, this paper aims to improve the performance of cancer classification based on RNA-Seq data through innovative methods and deepen the understanding of cancer mechanisms.